-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Reiterates Hold on Integra Lifesciences, Lowers Price Target to $13

Benzinga·11/03/2025 15:25:27
Listen to the news
Truist Securities analyst Ravi Misra reiterates Integra Lifesciences (NASDAQ:IART) with a Hold and lowers the price target from $15 to $13.